Brief: Sutro Biopharma Q3 Revenue USD 9.693 Million
06/11/2025 21:30
Nov 06 (Reuters) - Sutro Biopharma Q3 net income USD -56.857 million. Q3 operating income USD -48.459 million Q3 operating expenses USD 58.152 million
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates